Vanguard Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660M | Buy |
|
|||||
|
2025
Q1 | $494M | Sell |
|
|||||
|
2024
Q4 | $576M | Buy |
|
|||||
|
2024
Q3 | $603M | Buy |
|
|||||
|
2024
Q2 | $660M | Buy |
|
|||||
|
2024
Q1 | $582M | Sell |
|
|||||
|
2023
Q4 | $719M | Sell |
|
|||||
|
2023
Q3 | $658M | Sell |
|
|||||
|
2023
Q2 | $596M | Buy |
|
|||||
|
2023
Q1 | $499M | Buy |
|
|||||
|
2022
Q4 | $512M | Buy |
|
|||||
|
2022
Q3 | $566M | Buy |
|
|||||
|
2022
Q2 | $452M | Buy |
|
|||||
|
2022
Q1 | $448M | Buy |
|
|||||
|
2021
Q4 | $365M | Buy |
|
|||||
|
2021
Q3 | $396M | Sell |
|
|||||
|
2021
Q2 | $505M | Buy |
|
|||||
|
2021
Q1 | $567M | Buy |
|
|||||
|
2020
Q4 | $692M | Buy |
|
|||||
|
2020
Q3 | $569M | Sell |
|
|||||
|
2020
Q2 | $726M | Buy |
|
|||||
|
2020
Q1 | $570M | Buy |
|
|||||
|
2019
Q4 | $723M | Sell |
|
|||||
|
2019
Q3 | $732M | Sell |
|
|||||
|
2019
Q2 | $826M | Buy |
|
|||||
|
2019
Q1 | $1.01B | Buy |
|
|||||
|
2018
Q4 | $639M | Buy |
|
|||||
|
2018
Q3 | $572M | Buy |
|
|||||
|
2018
Q2 | $456M | Buy |
|
|||||
|
2018
Q1 | $457M | Buy |
|
|||||
|
2017
Q4 | $508M | Buy |
|
|||||
|
2017
Q3 | $504M | Buy |
|
|||||
|
2017
Q2 | $501M | Buy |
|
|||||
|
2017
Q1 | $379M | Buy |
|
|||||
|
2016
Q4 | $433M | Buy |
|
|||||
|
2016
Q3 | $322M | Sell |
|
|||||
|
2016
Q2 | $205M | Buy |
|
|||||
|
2016
Q1 | $342M | Buy |
|
|||||
|
2015
Q4 | $511M | Sell |
|
|||||
|
2015
Q3 | $356M | Buy |
|
|||||
|
2015
Q2 | $494M | Buy |
|
|||||
|
2015
Q1 | $510M | Buy |
|
|||||
|
2014
Q4 | $449M | Buy |
|
|||||
|
2014
Q3 | $282M | Sell |
|
|||||
|
2014
Q2 | $250M | Sell |
|
|||||
|
2014
Q1 | $336M | Buy |
|
|||||
|
2013
Q4 | $306M | Buy |
|
|||||
|
2013
Q3 | $275M | Buy |
|
|||||
|
2013
Q2 | $180M | Buy |
|